Crispr Therapeutics Ag (CRSP) |
|
63.67 -1.28 (-1.97%)
|
06-04 16:00 |
|
Open: |
65.12 |
Pre. Close: |
64.95 |
|
High:
|
66.36 |
Low:
|
62.56 |
|
Volume:
|
687,543 |
Market Cap:
|
3,885M |
|
|
|
|
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
66.428 - 66.791 |
66.791 - 67.092 |
|
Low:
|
61.707 - 62.146 |
62.146 - 62.51 |
|
Close:
|
63.001 - 63.679 |
63.679 - 64.241 |
|
Technical analysis |
as of: 2020-06-04 4:30:03 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 82.93 One year: 96.86 |
| Support: |
Support1: 56.07 Support2: 46.84 |
| Resistance: |
Resistance1: 71.00 Resistance2: 82.93 |
| Pivot: |
64.65  |
| Moving Average: |
MA(5): 65.63 MA(20): 62.76
MA(100): 52.42 MA(250): 51.57 |
| MACD: |
MACD(12,26): 3.48 Signal(9): 3.90 |
| Stochastic oscillator: |
%K(14,3): 67.64 %D(3): 71.89 |
| RSI: |
RSI(14): 55.49 |
| 52-week: |
High: 74.00 Low: 32.30 Change(%): 48.5 |
| Average Vol(K): |
3-Month: 93065 10-Days: 94294 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CRSP has closed above bottom band by 42.5%. Bollinger Bands are 1.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 03 Jun 2020
Jun 03, 2020 - Crispr Therapeutics Ag (CRSP) CEO Samarth Kulkarni Sold $1.1 million of Shares - GuruFocus.com
Tue, 26 May 2020
CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Thu, 14 May 2020
News Flash: Analysts Just Made A Substantial Upgrade To Their CRISPR Therapeutics AG (NASDAQ:CRSP) Forecasts - Yahoo Finance
Thu, 04 Jun 2020
July 24th Options Now Available For CRISPR Therapeutics (CRSP) - Nasdaq
Thu, 14 May 2020
Crispr Therapeutics AG (CRSP) Received its Third Buy in a Row - Smarter Analyst
Fri, 15 May 2020
CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting - GlobeNewswire
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
61 |
| Shares Float (M) |
46 |
|
% Held by Insiders
|
20.94 |
|
% Held by Institutions
|
55.73 |
|
Shares Short (K)
|
4,020 |
|
Shares Short P. Month (K)
|
3,270 |
Stock Financials |
|
EPS
|
0.770 |
|
EPS Est This Year
|
-2.430 |
|
EPS Est Next Year
|
-3.020 |
|
Book Value (p.s.)
|
14.550 |
|
Profit Margin
|
15.73 |
|
Operating Margin
|
7.46 |
|
Return on Assets (ttm)
|
1.8 |
|
Return on Equity (ttm)
|
7.2 |
|
Qtrly Rev. Growth
|
-52.1 |
|
Gross Profit (p.s.)
|
1.806 |
|
Sales Per Share
|
4.743 |
|
EBITDA (p.s.)
|
0.452 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
48 |
|
Levered Free Cash Flow (M)
|
55 |
Stock Valuations |
|
PE Ratio
|
82.69 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.38 |
|
Price to Sales
|
13.42 |
|
Price to Cash Flow
|
80.54 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
